Literature DB >> 7608584

"Atypical" fibro-osseous lesions: diagnostic challenges and treatment concepts.

M E Koury1, J A Regezi, D H Perrott, L B Kaban.   

Abstract

The term fibro-osseous lesion is a generic designation of a group of jaw disorders (ranging from inflammatory to neoplastic) that microscopically exhibit, a connective-tissue matrix and islands/trabeculae of bone. Although the histologic appearance, and frequently the clinical and radiographic features, may be similar for many of these lesions, they demonstrate a wide range of biologic behavior. Treatment therefore is varied, and there are few well-established guidelines to help the surgeon. Five fibro-osseous lesions with atypical features are presented to demonstrate the diagnostic difficulties associated with these lesions and to show the need for accurate classification in order to help direct treatment and predict outcome. Final diagnoses for "atypical" fibro-osseous lesions included: multiple ossifying fibromas, unclassifiable fibro-osseous lesion, osteosarcoma with concomitant multiple ossifying fibromas, juvenile or psammomatoid ossifying fibroma, and central low-grade osteosarcoma. "Fibro-osseous lesion" should be viewed as a working diagnosis, and a definitive diagnosis should be actively sought; the addition of "atypical" to this designation suggests the likelihood of an aggressive lesion. Treatment of lesions having atypical and nonclassical microscopic features must be based on the biologic behavior of the tumor.

Entities:  

Mesh:

Year:  1995        PMID: 7608584     DOI: 10.1016/s0901-5027(06)80094-9

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  21 in total

1.  Bimaxillary presentation of central ossifying fibroma: a unique aggressive entity.

Authors:  Kiran Desai; Kavita Gupta; B S Manjunatha; Soniya Palan
Journal:  BMJ Case Rep       Date:  2013-06-16

2.  Extensive ossifying fibroma of jaw.

Authors:  Anand Kumar; D S Gupta; Sunit K Jurel; Ruchika Khanna; Manoj Yadav
Journal:  Natl J Maxillofac Surg       Date:  2014 Jul-Dec

3.  Gene expression profiling of craniofacial fibrous dysplasia reveals ADAMTS2 overexpression as a potential marker.

Authors:  Shang-Hui Zhou; Wen-Jun Yang; Sheng-Wen Liu; Jiang Li; Chun-Ye Zhang; Yun Zhu; Chen-Ping Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  Ipsilateral maxillo-mandibular ossifying fibroma.

Authors:  Amit Tyagi; Sunil Chaudhary; Vineet Gupta
Journal:  J Maxillofac Oral Surg       Date:  2012-04-04

5.  Huge ossifying fibroma of the maxilla.

Authors:  Hari Ram; Shadab Mohammad; Nuzhat Husain; Laxman R Malkunje
Journal:  J Maxillofac Oral Surg       Date:  2011-06-28

6.  The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.

Authors:  Abberly Lott Limbach; Mark W Lingen; James McElherne; Heather Mashek; Carrie Fitzpatrick; Elizabeth Hyjek; Reza Mostofi; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2020-02-05

7.  Sinonasal fibro-osseous hamartoma: case presentation and differential diagnosis with other fibro-osseous lesions involving the paranasal sinuses.

Authors:  A N Boudewyns; J J S van Dinther; C G Colpaert
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-09       Impact factor: 2.503

8.  Fibrous dysplasia of the maxilla: diagnostic reliability of the study image. Literature review.

Authors:  Massimo Fusconi; Michela Conte; Martina Pagliarella; Chiara De Vincentiis; Armando De Virgilio; Anna Teresa Benincasa; Simone Alessi; Andrea Gallo
Journal:  J Neurol Surg B Skull Base       Date:  2013-06-13

9.  Management and Treatment Outcomes of Maxillofacial Fibro-osseous Lesions: A Retrospective Study.

Authors:  K A Jeevan Kumar; P Krishna Kishore; A P Mohan; V Venkatesh; B Pavan Kumar; Divya Gandla
Journal:  J Maxillofac Oral Surg       Date:  2014-11-16

10.  Gnathic osteosarcomas, experience of four institutions from Turkey.

Authors:  Fetin R Yildiz; Arzu Avci; Omür Dereci; Behcet Erol; Bulent Celasun; Omer Gunhan
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.